EMV:ASX - EMVISION MEDICAL DEVICES - Monster run since March low

EMV is up over 800% since its March lows this year. EMVision is developing a portable brain scanner for rapid, point of care, stroke diagnosis and monitoring which sounds like a good space to be in. I have had an alert set at RSI(14) < 65 for a while now to try and get back into it at better value, but I'm sill waiting :)
From their about us:
EMVision Medical Devices Limited is focused on the development and commercialisation of medical imaging technology. The Company is developing and seeking to commercialise a potentially cost effective, portable, medical imaging device using electromagnetic microwave imaging for diagnosis and monitoring of stroke and other medical applications. The technology is the result of over 10 years of development by researchers at the University of Queensland. The team of approximately 30 researchers is led by co-inventors Professor Amin Abbosh, who is considered a global leader in electromagnetic microwave imaging, along with Professor Stuart Crozier, who created technology central to most MRI machines manufactured since 1997. EMVision’s CEO, Dr Ron Weinberger, is the Former Executive Director and CEO of Nanosonics' (ASX:NAN), a $1.65 billion market cap healthcare company. Dr Weinberger has over 25-years’ experience developing and commercialising medical devices. During his time at Nanosonics, Dr Weinberger codeveloped the company’s platform technology and launched their breakthrough product ‘Trophon’ globally, which would go on to become the gold standard for infection prevention. Dr Weinberger was instrumental in transforming Nanosonics from a research and development company to one of Australia’s leading medical device commercialisation success stories.
From their about us:
EMVision Medical Devices Limited is focused on the development and commercialisation of medical imaging technology. The Company is developing and seeking to commercialise a potentially cost effective, portable, medical imaging device using electromagnetic microwave imaging for diagnosis and monitoring of stroke and other medical applications. The technology is the result of over 10 years of development by researchers at the University of Queensland. The team of approximately 30 researchers is led by co-inventors Professor Amin Abbosh, who is considered a global leader in electromagnetic microwave imaging, along with Professor Stuart Crozier, who created technology central to most MRI machines manufactured since 1997. EMVision’s CEO, Dr Ron Weinberger, is the Former Executive Director and CEO of Nanosonics' (ASX:NAN), a $1.65 billion market cap healthcare company. Dr Weinberger has over 25-years’ experience developing and commercialising medical devices. During his time at Nanosonics, Dr Weinberger codeveloped the company’s platform technology and launched their breakthrough product ‘Trophon’ globally, which would go on to become the gold standard for infection prevention. Dr Weinberger was instrumental in transforming Nanosonics from a research and development company to one of Australia’s leading medical device commercialisation success stories.
NOT TRADING ADVICE. ALWAYS DO YOUR OWN RESEARCH.
MY SITES:
FIND TRENDING STOCKS: HigherHighs.com/
FIND AND SET TRAILING STOPS: SuperTrail.io
TRADINGVIEW TIPS: YouTube.com/@zAngus
MY SITES:
FIND TRENDING STOCKS: HigherHighs.com/
FIND AND SET TRAILING STOPS: SuperTrail.io
TRADINGVIEW TIPS: YouTube.com/@zAngus
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
NOT TRADING ADVICE. ALWAYS DO YOUR OWN RESEARCH.
MY SITES:
FIND TRENDING STOCKS: HigherHighs.com/
FIND AND SET TRAILING STOPS: SuperTrail.io
TRADINGVIEW TIPS: YouTube.com/@zAngus
MY SITES:
FIND TRENDING STOCKS: HigherHighs.com/
FIND AND SET TRAILING STOPS: SuperTrail.io
TRADINGVIEW TIPS: YouTube.com/@zAngus
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.